scorecardresearch
Add as a preferred source on Google
Tuesday, December 2, 2025
TopicVaccine

Topic: Vaccine

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

Hope for chikungunya vaccine: French drugmaker reports 99% immune response in Phase 3 trial

Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.

‘Very promising’: World’s first vaccine, tested in Vietnam, against African swine fever nears approval

After decades of failed attempts due to the complexity of the virus, two vaccines co-developed by US scientists being tested in large pilot schemes by Vietnamese companies, WHO said.

People lost faith in childhood vaccines during Covid pandemic, says UNICEF report

The data was a 'worrying warning signal' of rising vaccine hesitancy amid misinformation, dwindling trust in governments and political polarisation, UNICEF said.

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

Covid, low awareness, vaccine hesitancy — why Mumbai’s reeling from a measles outbreak

From 92% vaccination in 2019-20, the number of those given 1st dose dropped to 74% in 2021-22. This year, only 43% children in Mumbai had received 1st dose till October.

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

How ICAR grew 50 generations of virus over 1.5 years to develop lumpy skin disease vaccine

Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.

On Camera

Desi weddings are now fake, vapid, meaningless extravaganzas. Billionaires pop out of nowhere

Once you sign up for a celebrity-driven destination ‘event’, you are held hostage for three days that test your sanity and stamina, unless you are Ranveer Singh, who always looks like he is having the best time.

New cess on ‘pan masala’ to fund national security and healthcare programmes

The Health Security Se National Security Cess Bill, 2025, explained. Oppn has attacked the proposed cess as 'a new financial burden' on the citizens.

After Op Sindoor, India goes in for more Heron Mk IIs; Israel frontrunner for mega MALE drones deal

Order for 87 MALE drones will be split between 2 Indian firms in 64:36 ratio to ensure there are 2 independent manufacturing lines with at least 60% indigenous components.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.